Abstract
BackgroundIn sub-Saharan Africa, children with Plasmodium falciparum malaria and anaemia are often given iron supplementation at the time of malaria treatment. Inflammation during and after malaria may decrease iron absorption, thus, absorption might be improved if the start of supplementation is delayed. The study objective was to measure iron absorption from iron supplements started immediately or delayed by two weeks after completion of therapy against uncomplicated P. falciparum malaria.MethodsMalawian toddlers (n = 48; age 12–24 months) were alternatively assigned to two groups according to their appearance at the health centre: group A was provided iron supplements (30 mg Fe daily) as a FeSO4-containing syrup for eight weeks starting immediately after malarial treatment; group B was given the iron after a two-week delay. Iron absorption from the syrup was measured on the first day of iron supplementation, and after two and eight weeks in both groups. Haemoglobin (Hb), iron status and inflammation were assessed every two weeks. Fractional iron absorption at each time point and cumulative absorption was quantified by measuring erythrocyte incorporation of 57Fe and compared using mixed models.ResultsComparing group A and B, geometric mean iron absorption did not differ on the first day of supplementation (9.0% vs. 11.4%, P = 0.213) and cumulative iron absorption from the three time points did not differ (6.0% vs. 7.2%, P = 0.124). Hb concentration increased in both groups two weeks after malaria treatment (P < 0.001) and did not differ after eight weeks of supplementation (P = 0.542).ConclusionsIn anaemic toddlers after uncomplicated malaria, a two-week delay in starting iron supplementation did not significantly increase iron absorption or Hb concentration. Iron absorption is sufficiently high in the immediate post-malaria period to warrant supplementation. These findings suggest there is no need to change the current practice of immediate iron supplementation in this setting.Trial registrationThis trial was registered at Pan African Clinical Trials Registry (pactr.org) as PACTR2010050002141682.
Highlights
Anaemia affects more than 1.7 billion people worldwide [1]
Malarial anaemia is caused by a combination of red cell lysis and inflammation
In a child presenting with malaria and anaemia, the anaemia may be due to red cell lysis, nutritional iron deficiency and inflammation caused by the infection
Summary
In low-income countries of sub-Saharan Africa, major causes of anaemia are infectious diseases, malaria, and diets low in bioavailable iron [2,3]. High levels of pro‐inflammatory cytokines increase serum hepcidin and this limits the release of recycled red cell iron sequestered in macrophages and other reticuloendothelial cells [4] and reduces dietary iron absorption [5,6]. Both mechanisms decrease the amount of circulating iron resulting in impaired erythropoiesis and the anaemia of inflammation [7]. The study objective was to measure iron absorption from iron supplements started immediately or delayed by two weeks after completion of therapy against uncomplicated P. falciparum malaria
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
